Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Embolic Protection Devices Market - Global Forecast to 2023

Research and Markets
Posted on: 28 Feb 18
Embolic Protection Devices Market - Global Forecast to 2023

PR Newswire

DUBLIN, Feb. 28, 2018

DUBLIN, Feb. 28, 2018 /PRNewswire/ --

The "Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023" report has been added to's offering.

The global embolic protection device market is projected to reach USD 604.9 Million by 2023 from USD 405.5 Million in 2018, at a CAGR of 8.3%.

Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. On the other hand, product failures and recalls may hinder the overall market growth to a certain extent during the forecast period.

In this report the global embolic protection device market is segmented on the basis of type & material, application, indication, end users and region.

Geographically, the embolic protection device market is segmented into North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. In 2017, North America dominated the global market. The rising geriatric population, prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding, and presence of a large number of medical device product manufacturers are driving the growth of the embolic protection devices market in North America. Asia Pacific, on the other hand, is expected to grow at the highest CAGR during the forecast period due to the growing number of prescriptions for people aged 65 or above, increasing healthcare spending, rising healthcare costs, and increasing target population.

Prominent players in the embolic protection device market are Boston Scientific (US), Medtronic Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical Solutions (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).

Market Dynamics


  • Rising Incidence of Cardiovascular & Neurovascular Diseases
  • Funding and Investments for R&D on Embolic Protection Devices
  • Technological Advancements
  • Rising Demand for Minimally Invasive Procedures


  • Product Failure and Recalls


  • Growth Opportunities in Emerging Markets


  • Stringent Regulatory Scenario and Unfavorable Government Policies
  • Dearth of Skilled Professionals

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Embolic Protection Device Market, By Type & Material

7 Embolic Protection Device Market, By Application

8 Embolic Protection Device Market, By Indication

9 Embolic Protection Device Market, By End User

10 Embolic Protection Device Market, By Region

11 Competitive Landscape

12 Company Profiles

  • Abbott Laboratories
  • Allium Medical Solutions
  • Angioslide
  • Boston Scientific
  • Claret Medical
  • Contego Medical
  • Cordis (A Cardinal Health Company)
  • Medtronic
  • Silk Road Medical
  • W. L. Gore & Associates

For more information about this report visit


Media Contact:

Laura Wood, Senior Manager  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets

PR Newswire

Last updated on: 28/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.